This panel will explore section 101 patentability issues as they relate to medical innovation (in particular diagnostic technology). The panel will be moderated by Professor Laura Pedraza-Fariña, and feature panelists who have first-hand knowledge of medical technology and the law. Below are papers relevant to the medical technology panel. https://www.supremecourt.gov/opinions/11pdf/10-1150.pdf http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/14-1139.Opinion.6-10-2015.1.PDF http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/15-1570.Opinion.6-30-2016.1.PD
Moderator: Michael Mireles, Associate Professor of Law, University of the Pacific, McGeorge School o...
Panel discussion: Limelight Networks v. Akamai Technologies and Medtronic v. Mirowski Family Venture...
Patent Issues Relative to Life Sciences R&D - Moving from Discovery in Academia to Commercialization...
This panel will explore section 101 patentability issues as they relate to medical innovation (in pa...
Laura Pedraza-Fariña: I’m really excited to moderate this discussion, which is going to center mainl...
Legal technology has greatly changed the practice of law, and will continue to have an impact as new...
The medical diagnostics market is expected to reach 65 billion by 2018. In March 2012, in Mayo Collb...
Please join us for a panel discussing gene patenting and related legal developments. Our distinguish...
Antibody-based Diagnostics (Shawn Owen, PhD); Real-time, web-based genomic big data analysis (Alista...
Moderator: David Clough, partner, Morgan, Lewis & Bockius This panel discusses the Myriad Genetics S...
This panel will discuss intellectual property - the patent incentive, patentability issues, licensin...
KSR is a big case because it addresses the only significant patentability requirement that exists un...
Intellectual property protection in the form of secured patents has played an integral role in the g...
To support emerging technologies the interests of the innovators of today must be carefully balanced...
Panelists at the Patent II Panel discuss Teva Pharmaceuticals v. Sandoz during the sixth annual Supr...
Moderator: Michael Mireles, Associate Professor of Law, University of the Pacific, McGeorge School o...
Panel discussion: Limelight Networks v. Akamai Technologies and Medtronic v. Mirowski Family Venture...
Patent Issues Relative to Life Sciences R&D - Moving from Discovery in Academia to Commercialization...
This panel will explore section 101 patentability issues as they relate to medical innovation (in pa...
Laura Pedraza-Fariña: I’m really excited to moderate this discussion, which is going to center mainl...
Legal technology has greatly changed the practice of law, and will continue to have an impact as new...
The medical diagnostics market is expected to reach 65 billion by 2018. In March 2012, in Mayo Collb...
Please join us for a panel discussing gene patenting and related legal developments. Our distinguish...
Antibody-based Diagnostics (Shawn Owen, PhD); Real-time, web-based genomic big data analysis (Alista...
Moderator: David Clough, partner, Morgan, Lewis & Bockius This panel discusses the Myriad Genetics S...
This panel will discuss intellectual property - the patent incentive, patentability issues, licensin...
KSR is a big case because it addresses the only significant patentability requirement that exists un...
Intellectual property protection in the form of secured patents has played an integral role in the g...
To support emerging technologies the interests of the innovators of today must be carefully balanced...
Panelists at the Patent II Panel discuss Teva Pharmaceuticals v. Sandoz during the sixth annual Supr...
Moderator: Michael Mireles, Associate Professor of Law, University of the Pacific, McGeorge School o...
Panel discussion: Limelight Networks v. Akamai Technologies and Medtronic v. Mirowski Family Venture...
Patent Issues Relative to Life Sciences R&D - Moving from Discovery in Academia to Commercialization...